176.93
Jazz Pharmaceuticals Plc (JAZZ) 最新ニュース
A Look at Jazz Pharmaceuticals's Valuation After Landmark HERIZON-GEA-01 Ziihera Trial Results - simplywall.st
Why Jazz Pharmaceuticals plc (J7Z) stock remains stableEarnings Performance Report & Verified Short-Term Plans - newser.com
What MACD trends signal for Jazz Pharmaceuticals plc (J7Z) stock2025 Winners & Losers & Capital Efficiency Focused Ideas - newser.com
How strong is Jazz Pharmaceuticals plc stock balance sheetJuly 2025 Levels & Real-Time Stock Movement Alerts - newser.com
Jazz Pharmaceuticals Insider Sold Shares Worth $3,259,538, According to a Recent SEC Filing - MarketScreener
Cozadd Bruce C, director at Jazz Pharmaceuticals, sells $3.2 million in stock By Investing.com - Investing.com South Africa
Insider Sell: Rick Winningham Sells 5,500 Shares of Jazz Pharmac - GuruFocus
Cozadd Bruce C, director at Jazz Pharmaceuticals, sells $3.2 million in stock - Investing.com India
Iannone, Jazz Pharmaceuticals EVP, sells $1.2m in JAZZ stock By Investing.com - Investing.com South Africa
Why Jazz Pharmaceuticals plc (J7Z) stock appeals to dividend investorsChart Signals & Entry Point Confirmation Alerts - newser.com
Is Jazz Pharmaceuticals plc (J7Z) stock undervalued at current priceQuarterly Growth Report & Stock Timing and Entry Methods - newser.com
Jazz Pharmaceuticals Insider Sold Shares Worth $1,204,573, According to a Recent SEC Filing - MarketScreener
Will Jazz Pharmaceuticals plc (J7Z) stock rise with strong economy2025 Geopolitical Influence & Fast Entry Momentum Trade Alerts - newser.com
What technical charts say about Jazz Pharmaceuticals plc stockWeekly Gains Summary & AI Forecast for Swing Trade Picks - newser.com
No-Moat Jazz's Growth Supported by Positive Phase 3 Data for Ziihera and Strong Uptake of Xywav - Morningstar
Insider Sell: Robert Iannone Sells Shares of Jazz Pharmaceuticals PLC - GuruFocus
Iannone, Jazz Pharmaceuticals EVP, sells $1.2m in JAZZ stock - Investing.com India
Will Jazz Pharmaceuticals plc (J7Z) stock outperform benchmarksRisk Management & Weekly Chart Analysis and Guides - newser.com
Technical analysis overview for Jazz Pharmaceuticals plc stockTrade Risk Assessment & Growth Focused Entry Point Reports - newser.com
Visual analytics tools that track Jazz Pharmaceuticals plc performanceMarket Growth Review & Free Fast Gain Swing Trade Alerts - newser.com
Truist Adjusts Price Target on Jazz Pharmaceuticals Public to $220 From $205, Maintains Buy Rating - MarketScreener
Jazz Pharmaceuticals (JAZZ) Is Up 32.0% After Positive Phase 3 Results for Ziihera in HER2-Positive Cancer - simplywall.st
Can Jazz Pharmaceuticals plc stock resist sector downturnsWeekly Trade Review & Expert Verified Stock Movement Alerts - newser.com
Why Jazz Pharmaceuticals plc (J7Z) stock could be next leaderJuly 2025 Action & Community Consensus Picks - newser.com
Is Jazz Pharmaceuticals’ Rally A Buying Signal? - StocksToTrade
Single Trial Success Stories: UCB’s Kygevvi Joins US FDA Approvals With Confirmatory Evidence - Citeline News & Insights
大文字化:
|
ボリューム (24 時間):